Pharmaceutical

Booster Therapeutics to develop proteasome activator medicines

Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.

Oct 12, 2024 - 04:00
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.
Read the original article

Tags:

Previous Article

Activist investor Starboard cries foul play in exec U-turn at Pfizer

Next Article

KeyBioscience and Eli Lilly extend partnership for obesity treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We’re reading about Sanders targeting pharma CEOs, insider trading, and more

STAT+: Pharmalittle: We’re reading about Sanders target...

Jan 20, 2024

STAT+: FDA approves AstraZeneca, Ionis treatment for rare nerve disease

STAT+: FDA approves AstraZeneca, Ionis treatment for ra...

Dec 23, 2023

Dobbs decision leaving broad imprint on reproductive medicine

Dobbs decision leaving broad imprint on reproductive me...

Oct 20, 2023